Your browser doesn't support javascript.
loading
Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial.
Reich, Kristian; Thyssen, Jacob P; Blauvelt, Andrew; Eyerich, Kilian; Soong, Weily; Rice, Zakiya P; Hong, H Chih-Ho; Katoh, Norito; Valenzuela, Fernando; DiBonaventura, Marco; Bratt, Tamara A; Zhang, Fan; Clibborn, Claire; Rojo, Ricardo; Valdez, Hernan; Kerkmann, Urs.
Afiliação
  • Reich K; University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. Electronic address: k.reich@uke.de.
  • Thyssen JP; Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Blauvelt A; Oregon Medical Research Center, Portland, OR, USA.
  • Eyerich K; University of Freiburg, Freiburg, Germany.
  • Soong W; AllerVie Health-Alabama Allergy & Asthma Center, Birmingham, AL, USA.
  • Rice ZP; Dermatology Associates of Georgia, Atlanta, GA, USA.
  • Hong HC; University of British Columbia, Vancouver, BC, Canada.
  • Katoh N; Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
  • Valenzuela F; University of Chile and Probity Medical Research, Santiago, Chile.
  • DiBonaventura M; Pfizer, New York, NY, USA.
  • Bratt TA; Pfizer, Groton, CT, USA.
  • Zhang F; Pfizer, Groton, CT, USA.
  • Clibborn C; Pfizer, Surrey, UK.
  • Rojo R; Pfizer, Groton, CT, USA.
  • Valdez H; Pfizer, New York, NY, USA.
  • Kerkmann U; Pfizer Pharma, Berlin, Germany.
Lancet ; 400(10348): 273-282, 2022 07 23.
Article em En | MEDLINE | ID: mdl-35871814

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatite Atópica Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatite Atópica Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article